These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6270215)

  • 1. Antistaphylococcal activity of rifampin with other antibiotics.
    Zinner SH; Lagast H; Klastersky J
    J Infect Dis; 1981 Oct; 144(4):365-71. PubMed ID: 6270215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Killing rate and serum bactericidal activity of oxacillin, rifampin and ciprofloxacin against Staphylococcus aureus.
    Moretti MV; Fiorio M; Pasticci MB; Moretti A; Baldelli F; Pauluzzi S
    Microbiologica; 1989 Oct; 12(4):297-306. PubMed ID: 2586332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between rifampin and fusidic acid against methicillin-resistant coagulase-positive and -negative staphylococci.
    Farber BF; Yee YC; Karchmer AW
    Antimicrob Agents Chemother; 1986 Jul; 30(1):174-5. PubMed ID: 3638931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of clindamycin in combination with oxacillin, rifampin, or vancomycin against Staphylococcus aureus.
    Ho JL; Klempner MS
    Diagn Microbiol Infect Dis; 1986 Feb; 4(2):133-8. PubMed ID: 3956136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antistaphylococcal activity of pefloxacin alone and in combination with other antistaphylococcal drugs.
    Fass RJ; Helsel VL
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1457-60. PubMed ID: 3481244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci].
    Fosse T; David MF; Duluc F; Darmusey D; Tamalet C; Toga B
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):528-31. PubMed ID: 6462742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antibiotics, alone and in combination, on Panton-Valentine leukocidin production by a Staphylococcus aureus reference strain.
    Dumitrescu O; Badiou C; Bes M; Reverdy ME; Vandenesch F; Etienne J; Lina G
    Clin Microbiol Infect; 2008 Apr; 14(4):384-8. PubMed ID: 18261123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of rifapentine and rifampin, alone and in combination with six other antibiotics, against methicillin-susceptible and methicillin-resistant staphylococci of different species.
    Varaldo PE; Debbia E; Schito GC
    Antimicrob Agents Chemother; 1985 Apr; 27(4):615-8. PubMed ID: 3847272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
    Drugeon HB; Caillon J; Juvin ME
    J Antimicrob Chemother; 1994 Dec; 34(6):899-907. PubMed ID: 7730233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect of quinolones and oxacillin on methicillin-resistant Staphylococcus species.
    Rohner P; Herter C; Auckenthaler R; Pechère JC; Waldvogel FA; Lew DP
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2037-41. PubMed ID: 2619272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of rifampin in combination with oxacillin against Staphylococcus aureus.
    Maduri Traczewski M; Goldmann DA; Murphy P
    Antimicrob Agents Chemother; 1983 Apr; 23(4):571-6. PubMed ID: 6859835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of minocycline and rifampin against staphylococci.
    Segreti J; Gvazdinskas LC; Trenholme GM
    Diagn Microbiol Infect Dis; 1989; 12(3):253-5. PubMed ID: 2791487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus.
    Bayer AS; Morrison JO
    Antimicrob Agents Chemother; 1984 Aug; 26(2):220-3. PubMed ID: 6567464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
    Ishag AJ; Durgham SM; Shibl AM
    Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
    Soriano A; Jurado A; Marco F; Almela M; Ortega M; Mensa J
    Rev Esp Quimioter; 2005 Jun; 18(2):168-72. PubMed ID: 16130039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination between fosfomycin and oxacillin or cefotaxime against methicillin-resistant Staphylococci and Enterococci].
    Duez JM; Kohli E; Pechinot A; Tremeaux JC; Kazmierczak A
    Pathol Biol (Paris); 1983 Jun; 31(6):515-8. PubMed ID: 6308543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
    Quentin C; Saivin S; Lafferriere C; Noury P; Bebear C
    Drugs Exp Clin Res; 1987; 13(4):219-24. PubMed ID: 3476291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus.
    Foldes M; Munro R; Sorrell TC; Shanker S; Toohey M
    J Antimicrob Chemother; 1983 Jan; 11(1):21-6. PubMed ID: 6826485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of novobiocin and rifampin alone and in combination against oxacillin-resistant Staphylococcus aureus.
    Johnston BL; Kwok RY; Mulligan ME
    Diagn Microbiol Infect Dis; 1987 Nov; 8(3):137-47. PubMed ID: 3440369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of ceftazidime in combination with other antibiotics.
    Simon C; Littschwager G
    Infection; 1985; 13(4):184-9. PubMed ID: 3930407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.